Back

Blueprint Medicines Quote, Financials, Valuation and Earnings

Buy

BPMC
Blueprint Medicines

Last Price:

106.67

Seasonality Move:

13.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Blueprint Medicines Price Quote

$106.67

-0.12 (-0.11%)

(Updated: May 16, 2024 at 6:55 PM ET)

Blueprint Medicines Key Stats

Buy

Blueprint Medicines (BPMC) is a Buy

Day range:

$106.09 - $108.75

52-week range:

$43.89 - $111.02

Dividend yield:

P/E ratio:

0.00

P/S ratio:

23.26

P/B ratio:

21.52%

Volume:

758.1K

Avg. volume:

680K

1-year change:

93.67%

Market cap:

$6.7B

Revenue:

$249.4M

EPS:

$-4.81

How Much Does Blueprint Medicines Make?

How Much Are Blueprint Medicines's Sales Annually?
BPMC Revenues are $249.4M
How Much Profit Does Blueprint Medicines's Make A Year?
BPMC net income is -$507M

Is Blueprint Medicines Growing As A Company?

What Is Blueprint Medicines's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.52%
What Is Blueprint Medicines's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Blueprint Medicines Stock Price Performance

Did Blueprint Medicines Stock Go Up Last Month?
Blueprint Medicines share price went up by 25.37% last month
Did BPMC's Share Price Rise Over The Last Year?
BPMC share price rose by 93.67% over the past 1 year

What Is Blueprint Medicines 52-Week High & Low?

What Is Blueprint Medicines’s 52-Week High Share Price?
Blueprint Medicines has traded as high as $111.02 over the past 52 weeks
What Is Blueprint Medicines’s 52-Week Low Share Price?
Blueprint Medicines has traded as low as $43.89 over the past 52 weeks

Blueprint Medicines Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Blueprint Medicines?

How Much Debt Does Blueprint Medicines Have?
Total long term debt quarterly is $239.4M
How Much Cash Does Blueprint Medicines Have?
Cash and short term investments quarterly total is $647.9M
What Is Blueprint Medicines’s Book Value Per Share?
Book value per share is 4.96

Is Blueprint Medicines Cash Flow Positive?

What Is BPMC Cash Flow From Operations?
Cash flow from operations (TTM) is -$415.4M
What Is Blueprint Medicines’s Cash Flow From Financing?
Cash flow from financing (TTM) is $186.2M
What Is Blueprint Medicines’s Cash Flow From Investing?
Cash flow from investing (TTM) is $178.4M

Blueprint Medicines Return On Invested Capital

Is Management Doing A Good Job?
BPMC return on invested capital is -60.94%
What Is Blueprint Medicines Return On Assets?
ROA measures how assets are converting to revenues and is -26.11%
What Is BPMC Return On Equity?
ROE is a measure of profitability and is -105.27%

Blueprint Medicines Earnings Date & Stock Price

What Is Blueprint Medicines's Stock Price Today?
A single share of BPMC can be purchased today for 106.79
What Is Blueprint Medicines’s Stock Symbol?
Blueprint Medicines trades on the nasdaq under the ticker symbol: BPMC
When Is Blueprint Medicines’s Next Earnings Date?
The next quarterly earnings date for Blueprint Medicines is scheduled on August 2, 2024
When Is BPMC's next ex-dividend date?
Blueprint Medicines's next ex-dividend date is May 17, 2024
How To Buy Blueprint Medicines Stock?
You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Blueprint Medicines Competitors

Who Are Blueprint Medicines's Competitors?
Below is a list of companies who compete with Blueprint Medicines or are related in some way:
- Alnylam Pharmaceuticals Inc (ALNY)
- Apellis Pharmaceuticals Inc (APLS)
- Biomarin Pharmaceutical Inc (BMRN)
- Corcept Therapeutics Inc (CORT)
- Ligand Pharmaceuticals Inc (LGND)

Blueprint Medicines Dividend Yield